BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 12, 2011
View Archived Issues
New cannabinoid CB2 receptor agonists discovered
Read More
AstraZeneca patents new diacylglycerol O-acyltransferase 1 inhibitors
Read More
New melanin-concentrating hormone MCH1 receptor antagonists disclosed
Read More
Merck & Co. claims novel gamma-secretase modulators
Read More
Chimerix begins enrollment in open-label study of CMX-001
Read More
Antimalarial artesunate has anticancer properties that can be enhanced by combination therapy
Read More
PC-1005 gel protects monkeys from infection with simian HIV
Read More
Studies examine pharmacodynamics and antidepressant efficacy of LY-2216684
Read More
Zydus-Cadila discloses new GPR119 receptor agonists
Read More
Immutep and GSK enter into agreement for ImmuTune IMP-731
Read More
Cylene Pharmaceuticals identifies novel protein kinase inhibitors
Read More
Isis expands pipeline with ISIS-STAT3Rx and ISIS-FGFR4Rx
Read More
NPS Pharma concludes treatment in phase III STEPS trial of Gattex
Read More
CeNeRx BioPharma begins phase II trial of modified-release CX-157
Read More
Daiichi Sankyo launches Cravit intravenous injections in Japan
Read More
MacroGenics begins phase I study of MGAH-22 in HER2-positive tumors
Read More
Bristol-Myers Squibb and Pharmasset to evaluate combination treatment for chronic hepatitis C
Read More
Phase III trial begins for lubiprostone in opioid-induced bowel dysfunction
Read More
Seattle Genetics and Pfizer join to develop anticancer antibody-drug conjugates
Read More
New unbiased approach described for discovery of IgG biomarkers with diagnostic potential
Read More
Esperion begins phase II trial of ETC-1002 in lipid regulation
Read More
Phase II data reported on LCP-Tacro in de novo liver transplant recipients
Read More
Dara BioSciences presents additional data from phase I DB-959 trial
Read More
EffRx Pharma submits NDA to FDA for EX-101
Read More
FDA grants marketing approval for diaDexus' automated PLAC test
Read More